Assessment of Efficacy & Safety for a New Wound Dressing Urgo 310 3166 in the Local Treatment of VLU or Mixed Leg Ulcers

Assessment of Efficacy and Safety for a New Wound Dressing URGO 310 3166 in the Local Treatment of Venous or Mixed Leg Ulcers: A European, Randomised Clinical Trial

Assessment of efficacy and safety for a new wound dressing URGO 310 3166 in the local treatment of venous or mixed leg ulcers: a European, randomised clinical trial.

Inclusion Criteria:

• Patient over 18 years old who has provided his/her written informed consent,
• Patient who can be monitored by the same investigation team throughout the whole duration of the study,
• Patient who agrees to wear an effective venous compression system every day, associated with the trial dressing,
• Leg ulcer with an Ankle Brachial Pressure Index (ABPI) not less than 0.7 and not more than 1.3,
• Ulcer area > or equal to 5cm2,
• Ulcer duration > or equal to 6 months,
• Ulcer presenting a the surface wound bed covered with 50% or more by sloughy tissue,
• Moderately or heavily exudative ulcers.

Exclusion Criteria:

• Clinical infection on the wound bed.